"Myelodysplastic-Myeloproliferative Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES or MYELOPROLIFERATIVE DISORDERS.
- Myelodysplastic-Myeloproliferative Diseases
- Disease, Myelodysplastic-Myeloproliferative
- Diseases, Myelodysplastic-Myeloproliferative
- Myelodysplastic Myeloproliferative Diseases
- Myelodysplastic-Myeloproliferative Disease
- Myeloproliferative-Myelodisplastic Diseases
- Disease, Myeloproliferative-Myelodisplastic
- Diseases, Myeloproliferative-Myelodisplastic
- Myeloproliferative Myelodisplastic Diseases
- Myeloproliferative-Myelodisplastic Disease
Below are MeSH descriptors whose meaning is more general than "Myelodysplastic-Myeloproliferative Diseases".
Below are MeSH descriptors whose meaning is more specific than "Myelodysplastic-Myeloproliferative Diseases".
This graph shows the total number of publications written about "Myelodysplastic-Myeloproliferative Diseases" by people in this website by year, and whether "Myelodysplastic-Myeloproliferative Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Myelodysplastic-Myeloproliferative Diseases" by people in Profiles.
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms. Leukemia. 2022 Dec; 36(12):2934-2938.
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms. Virchows Arch. 2022 Oct; 481(4):621-646.
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves. Transplant Cell Ther. 2021 05; 27(5):438.e1-438.e6.
Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1. Mod Pathol. 2021 01; 34(1):20-31.
Lymphoblastic leukemia following MDS or MDS/MPN: clinical evidence for stem cell origins of these disorders. Leuk Lymphoma. 2019 12; 60(12):2847-2848.
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood. 2014 Apr 24; 123(17):2645-51.
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact. 2010 Mar 19; 184(1-2):16-20.
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30; 114(5):937-51.